Literature DB >> 16572115

Transforming growth factor beta regulates cyclooxygenase-2 in glomerular mesangial cells.

P Harding1, L Balasubramanian, J Swegan, A Stevens, W F Glass.   

Abstract

This study examines the hypothesis that transforming growth factor beta (TGFbeta) regulates cyclooxygenase-2 (COX-2) and induces prostaglandin E synthase (mPGES-1) in rat mesangial cells. COX-2 expression was determined by Northern blot analysis after treatment with either TGFbeta1 or the selective COX-2 inhibitor, NS398. mPGES-1 expression was determined by real-time polymerase chain reaction. The effect of TGFbeta1 on COX-2 gene transcription was assessed using a luciferase reporter assay, and mRNA stability was also determined. To determine whether TGFbeta1 activates elements of the COX-2 promoter, we performed gel shift analyses to examine activation of activator protein-1 (AP-1) and nuclear factor kappaB (NF-kappaB). Prostaglandin E(2) (PGE(2)) and thromboxane B2 (TxB2) production was assayed by enzyme immunoassay. Finally, the pathophysiological relevance of COX-2 inhibition on the downstream effects of TGFbeta was assessed by examining collagen type I mRNA and net collagen production. COX-2 mRNA and mPGES-1 were induced after treatment with TGFbeta1 for 4 h, and this rise was accompanied by a three-fold increase in PGE(2) production that could be antagonized by selective inhibition of COX-2 with NS398. TGFbeta1 increased transcription by approximately 50% and activated both AP-1 and NF-kappaB. These effects were antagonized by co-treatment with NS398. Treatment with TGFbeta1 also doubled the half-life of COX-2 mRNA. Neither collagen type I mRNA nor net collagen production were altered by co-treatment with NS398. In conclusion, these results indicate that TGFbeta stimulates COX-2 and mPGES-1, with additional effects on transcription and stability of COX-2 mRNA.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16572115     DOI: 10.1038/sj.ki.5000323

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  7 in total

1.  Transforming growth factor-β induces microRNA-29b to promote murine alveolar macrophage dysfunction after bone marrow transplantation.

Authors:  Racquel Domingo-Gonzalez; Carol A Wilke; Steven K Huang; Yasmina Laouar; Jeanette P Brown; Christine M Freeman; Jeffrey L Curtis; Gregory A Yanik; Bethany B Moore
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-10-31       Impact factor: 5.464

2.  Transforming Growth Factor-β1 Increases DNA Methyltransferase 1 and 3a Expression through Distinct Post-transcriptional Mechanisms in Lung Fibroblasts.

Authors:  Hailey B Koh; Anne M Scruggs; Steven K Huang
Journal:  J Biol Chem       Date:  2016-07-12       Impact factor: 5.157

3.  Upregulation of fibronectin expression by COX-2 is mediated by interaction with ELMO1.

Authors:  Chen Yang; Andrey Sorokin
Journal:  Cell Signal       Date:  2010-08-21       Impact factor: 4.315

4.  Involvement of p300/CBP and epigenetic histone acetylation in TGF-β1-mediated gene transcription in mesangial cells.

Authors:  Hang Yuan; Marpadga A Reddy; Guangdong Sun; Linda Lanting; Mei Wang; Mitsuo Kato; Rama Natarajan
Journal:  Am J Physiol Renal Physiol       Date:  2012-12-12

5.  20-Hydroxyeicosatetraenoic acid inhibits ATP-induced COX-2 expression via peroxisome proliferator activator receptor-α in vascular smooth muscle cells.

Authors:  Chan-Jung Liang; Ching-Ping Tseng; Chuen-Mao Yang; Yunn-Hwa Ma
Journal:  Br J Pharmacol       Date:  2011-06       Impact factor: 8.739

6.  Oryeongsan suppressed high glucose-induced mesangial fibrosis.

Authors:  Jung Joo Yoon; Yun Jung Lee; So Min Lee; Dae Gill Kang; Ho Sub Lee
Journal:  BMC Complement Altern Med       Date:  2015-02-22       Impact factor: 3.659

7.  EP4 inhibition attenuates the development of diabetic and non-diabetic experimental kidney disease.

Authors:  Karina Thieme; Syamantak Majumder; Angela S Brijmohan; Sri N Batchu; Bridgit B Bowskill; Tamadher A Alghamdi; Suzanne L Advani; M Golam Kabir; Youan Liu; Andrew Advani
Journal:  Sci Rep       Date:  2017-06-13       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.